Related Experiment Video
Updated: Jan 3, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life
Barbara Laughton1, Shalena Naidoo2, Els F M T Dobbels1
1Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Insights
Starting antiretroviral therapy (ART) within days of birth in HIV-infected infants shows normal early neurodevelopment. This early intervention is crucial for positive outcomes in infants with perinatal HIV.
Area of Science:
- Pediatric Infectious Diseases
- Neurodevelopmental Pediatrics
- Public Health
Background:
- Antiretroviral therapy (ART) initiated between 7-12 weeks improves neurodevelopment in HIV-infected infants.
- The effects of initiating ART even earlier, within 21 days of life, were not previously well-described.
Purpose of the Study:
- To assess the early neurodevelopmental outcomes of human immunodeficiency virus (HIV)-positive infants who commenced ART within 21 days of birth.
- To evaluate the impact of very early ART initiation on infant neurodevelopment.
Main Methods:
- Infants were enrolled from a public sector HIV diagnosis program, meeting criteria for birth weight, early ART initiation (<6 weeks), and absence of cytomegalovirus disease.
- ART regimens varied based on initial treatment and infant weight/gestational age, with Zidovudine/Lamivudine/Nevirapine followed by Lopinavir/Ritonavir, and later Abacavir substitution.
- Neurodevelopment was assessed using the Griffiths Mental Development Scales (GMDS) between 10-12 months of age.
Main Results:
- Twenty-nine HIV-infected infants were assessed, with 79% being female and 83% of mothers receiving ART during pregnancy.
- ART was initiated at a median of 6 days, with viral load suppression achieved by a median of 19.1 weeks.
- At 11.5 months, global and subscale neurodevelopmental quotients measured by GMDS were within the average range, despite 31% having detectable viral load at assessment.
Conclusions:
- Very early initiation of ART (median 6 days) in infants with perinatal HIV infection is associated with neurodevelopmental scores within the normal range.
- These preliminary findings in a small cohort suggest that timely ART commencement is beneficial for neurodevelopmental outcomes.
- Further research with larger cohorts is warranted to confirm these positive early neurodevelopmental findings.
Background:
Antiretroviral therapy (ART) started between 7 and 12 weeks of age improves neurodevelopmental outcomes in HIV-infected (HIV+) infants, but the impact of even earlier initiation is not yet described.
Objectives:
We assessed the early neurodevelopment of HIV+ infants who started ART within 21 days of life.
Method:
Participants were enrolled from the public sector birth HIV-diagnosis programme. Inclusion criteria included the following: birth weight > 2000 g, infant commencing ART < 6 weeks and no infant cytomegalovirus disease. Antiretroviral therapy included Zidovudine/Lamivudine/Nevirapine for the first 2 weeks, the latter then replaced by Lopinavir/Ritonavir. Once body weight > 3 kg and gestational age > 44 weeks, Abacavir replaced Zidovudine. The Griffiths mental development scales (GMDS) were administered at 10-12 months.
Results:
Of 29 infants assessed, 23 (79%) were girls. Mean birth weight was 3002 ± 501 g. Twenty-four mothers (83%) received ART during pregnancy. Seven (24%) infants were diagnosed HIV+ within 48 h of birth. Median [interquartile range] viral load (VL) at diagnosis was 3904 [259-16 922] copies/mL, age starting ART was 6.0 [3-10] days and age at VL suppression was 19.1 [15-36] weeks. At the GMDS assessment, nine (31%) participants had detectable VL and 26 (90%) had World Health Organization (WHO) clinical stage I disease. The GMDS was performed at a mean age of 11.5 ± 0.8 months. Mean quotients were within the average range: Global Griffiths score was 103.6 ± 10.9 and mean quotients on the subscales ranged from lowest 95.9 ± 13.4 for locomotor to highest 112.8 ± 11.3 for hearing-and-language.
Conclusion:
Preliminary findings in this small group suggest that early neurodevelopmental scores are within the normal range in infants with perinatal HIV infection who started ART at a median of 6 days.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
08:49Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
Published on: March 18, 2020
Related Concept Videos
Retrovirus Life Cycles
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Retroviruses
Pharmacokinetics in Pediatric Patients: Drug Excretion